文献速递生殖医学

新型灵活孕激素预处理卵巢刺激方案与灵活促性腺激素释放激素拮抗剂方案在辅助生殖技术中的比较

Comparison of a novel flexible progestin primed ovarian stimulation protocol and the flexible gonadotropin-releasing hormone antagonist protocol for assisted reproductive technology.
PubMed 文献 · Fertil Steril · 2019-07-29

回顾性队列研究纳入87名卵母细胞捐赠者和191名新鲜卵母细胞接受者,比较灵活孕激素预处理卵巢刺激(fPPOS)方案与灵活GnRH拮抗剂方案。两方案刺激时长和促性腺激素用量相似,均无提前排卵;fPPOS组卵丘卵母细胞复合体和中期II卵母细胞数显著更多,接受者妊娠结局相似。

要点

  • fPPOS方案与GnRH拮抗剂方案均无提前排卵,刺激时长和促性腺激素用量相似。
  • fPPOS组卵丘卵母细胞复合体数33(21-39)显著高于GnRH拮抗剂组26(18-36)。
  • fPPOS组中期II卵母细胞数24(17-34)显著高于GnRH拮抗剂组21(15-28)。

核心结论

  • 使用醋酸甲羟孕酮的fPPOS方案似乎是接受卵巢刺激女性预防提前排卵的有效选择,且不损害卵母细胞质量。

研究设计与样本

  • 回顾性队列研究,纳入87名卵母细胞捐赠者和191名新鲜卵母细胞接受者。
  • 每名捐赠者在6个月内分别接受一次灵活GnRH拮抗剂方案和一次fPPOS方案。
  • FSH于周期第2-3天开始,GnRH拮抗剂0.25 mg/天或醋酸甲羟孕酮10 mg/天于刺激第7天或领先卵泡达14 mm时(以先发生者为准)开始。

主要发现

  • 两方案刺激时长均为11(10-11)天,促性腺激素总用量相似。
  • 垂体抑制均于第7天开始并持续5天,两组均无提前排卵。
  • fPPOS组卵丘卵母细胞复合体数33(21-39)显著高于GnRH拮抗剂组26(18-36)。
  • fPPOS组中期II卵母细胞数24(17-34)显著高于GnRH拮抗剂组21(15-28)。
  • 接受fPPOS和GnRH拮抗剂周期新鲜卵母细胞的接受者,其卵裂率、囊胚形成率、种植率和活产/持续妊娠率相似(50% vs 48.6%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether a flexible progestin primed ovarian stimulation (fPPOS) protocol is effective for preventing premature ovulation. DESIGN: Retrospective cohort study. SETTING: Private assisted reproduction center. PATIENT(S): Eighty-seven oocyte donors and 191 recipients of fresh oocytes. INTERVENTION(S): Each donor was stimulated with a flexible gonadotropin-releasing hormone (GnRH) antagonist protocol in one cycle and with the new fPPOS protocol in the other, within a period of 6 months. FSH was started on cycle day 2-3, and 0.25 mg/day GnRH antagonist or 10 mg/day medroxyprogesterone acetate (MPA) was started on stimulation day 7 or when the leading follicle reached 14 mm, whichever came first. MAIN OUTCOME MEASURE(S): Duration of stimulation, gonadotropin consumption, duration of GnRH antagonist or MPA administration, number of metaphase II oocytes, and pregnancy rates in fresh oocyte recipients. RESULTS: Duration of stimulation was 11 (10-11) days in both groups. Total gonadotropin consumption was similar. Pituitary suppression was started on day 7 and lasted for 5 days in each group. There were no premature ovulations in any group. The fPPOS yielded a significantly higher number of cumulus oocyte complexes than GnRH antagonist cycles (33 [21-39] vs. 26 [18-36], respectively). Likewise, the fPPOS generated significantly more metaphase II oocytes than GnRH antagonist cycles (24 [17-34] vs. 21 [15-28], respectively). Recipients of fresh oocytes from fPPOS and GnRH antagonist cycles had similar cleavage, blastulation, implantation, and live birth/ongoing pregnancy rates (50% vs. 48.6%). CONCLUSION(S): FPPOS with MPA seems to be an effective choice for preventing premature ovulation in women undergoing ovarian stimulation without compromising oocyte quality.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Yildiz S, Turkgeldi E, Angun B, et al. Comparison of a novel flexible progestin primed ovarian stimulation protocol and the flexible gonadotropin-releasing hormone antagonist protocol for assisted reproductive technology. Fertil Steril. 2019. PMID: 31371053. doi:10.1016/j.fertnstert.2019.06.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。